Patrick O'Brien insider trades

Open-market stock purchases and sales by Patrick O'Brien, COO at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 2, 2014.

Recent trades

DateStockTradeValue
Jan 6, 2026ARWR Arrowhead Pharmaceuticals, IncSold (not open market)—
Jan 6, 2026ARWR Arrowhead Pharmaceuticals, IncSold (not open market)—
Jan 6, 2026ARWR Arrowhead Pharmaceuticals, IncBought (not open market)—
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$267K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$384K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$847K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$756K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$21.3K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$36.7K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$56K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$369K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$150K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$3.1K
Jan 5, 2026ARWR Arrowhead Pharmaceuticals, IncSold$174K
Dec 31, 2025ARWR Arrowhead Pharmaceuticals, IncSold (not open market)—

Companies traded

  • ARWR Arrowhead Pharmaceuticals, Inc: 48 sales, last Jan 6, 2026

Get free alerts when Patrick O'Brien files a new trade →